ÂÜÀòÂÒÂ×

Maria Luisa Grossi has a diverse work experience in the pharmaceutical and medical device sector. Maria Luisa is currently the Executive Director and Head of Commercial Strategy at Stemline Therapeutics since August 2022. Prior to that, they worked at Novartis Oncology as the Director of Strategy & Operations for the US Solid Tumor Franchise from January 2020 to August 2022. Before that, Maria worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as the Director of Strategy and Business Transformation from December 2018 to December 2019. Maria also has several years of experience at McKinsey & Company, where they held the roles of Engagement Manager from July 2015 to November 2018, Associate from September 2012 to June 2015, and Business Analyst from May 2008 to September 2012. Maria Luisa also had a summer internship at Endeavor in 2011. Throughout their career, Maria has demonstrated expertise in commercial strategy, go-to-market models, cross-functional strategic initiatives, and project management in various geographies.

Maria Luisa Grossi has a strong educational background in business administration, engineering, and applied physics. Maria Luisa obtained a Master of Business Administration (MBA) degree in Business Administration and Management from the London Business School from 2010 to 2012. Prior to that, they completed a Master's Degree in Electronics Engineering from Politecnico di Milano from 2006 to 2008. During the same period, they also pursued a Master's Degree in Electronics from Alta Scuola Politecnica. Maria began their educational journey by earning a Bachelor's Degree in Engineering Physics/Applied Physics from Politecnico di Milano from 2002 to 2005.

In addition to their formal education, Maria Luisa Grossi has obtained additional certifications. In October 2020, they completed the "Fighting Gender Bias at Work" certification from LinkedIn. Maria Luisa also obtained the "Unconscious Bias" certification from LinkedIn in the same month and year.